logo

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Strides Pharma Share Price

Strides Pharma Science Ltd.

961.85

24.10(2.57%)

Invest in STAR with up to 2.50x margin.

Trade with MTF
1st Apr 2026 | 2:51 PM
NSE : STAR
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Strides Pharma Performance

Price Movement

₹961.85

₹952.55

₹980.00

Today's LowToday's High

1 Year Performance

₹961.85

₹513.05

₹1025.00

52 Week Low52 Week High

Markets Today

High₹980.00
Low₹952.55
Open at₹956.00
Prev Close₹937.75
Volumes3.03 L
Avg Price₹969.12
Lower Circuit₹750.20
Upper Circuit₹1,125.30

Historical Performance

3M High₹1,010.30
3M Low₹768.65
1 Yr High₹1,025.00
1 Yr Low₹513.05
3 Yr High₹1,675.00
3 Yr Low₹285.00
5 Yr High₹1,675.00
5 Yr Low₹263.35

Strides Pharma Fundamentals

Market Cap
High in industry
8,643.50 Cr.
PE Ratio (TTM)
Below industry Median
16.90
Dividend Yield
Below industry Median
0.40
Net Profit TTM
89.7% incr over last year
511.44
Net Profit Growth
89.7% incr over last year
511.44
PEG Ratio
Above industry Median
0.20
ROE
4341.3% incr over last year
140.81
Operating Revenue TTM
4,725.61
Operating Revenue Growth
4.4% incr over last year
Book Value
Above industry Median
2.90
MFI
MFI Overbought
73.46
RSI
RSI is mid-range
63.84
EPS (TTM)
390.55
Debt to Equity
0.70
Face Value
10
Operating Profit Margin Qtr.
17.36
Operating Profit Qtr.
235.94
Net Profit Qtr.
202.11
Operating Revenue Qtr.
1,194.65
PB Ratio
2.90

Strides Pharma Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue553.63522.15498.62555.96550.92
Operating Expense472.43459.93431.38488.03476.82
Operating Profit81.2062.2267.2367.9374.10
Depreciation22.4021.5122.1422.3720.92
Interest27.2429.4130.4529.3634.21
Tax12.91-6.653.0612.206.44
Net Profit121.9032.0413.3516.1314.94

Strides Pharma Technicals

Strides Pharma Science Ltd. EMA & SMA

961.85

21.55 (2.29%)

Bullish Moving Average

16

Bearish Moving Average

0

Day EMA5 ₹927.4
Day EMA10 ₹915.4
Day EMA12 ₹911.6
Day EMA20 ₹900.5
Day EMA26 ₹895.4
Day EMA50 ₹887.8
Day EMA100 ₹882.3
Day EMA200 ₹873.2

Strides Pharma Support and Resistance

Resistance

First Resistance₹956.57
Second Resistance₹975.38
Third Resistance₹1000.87

Support

First Support₹912.27
Second Support₹886.78
Third Support₹867.97

Technical Indicators

Day RSI63.84
Day MFI73.46
Day ADX25.87
Day Commodity Channel Index103.90
William-17.39
Day MACD16.14
Day MACD Signal Line10.76
Day ATR32.71
Day ROC12511.72
Day ROC218.59

Strides Pharma Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter25.826.828.328.327.927.9
FII30.128.528.32828.529.5
DII18.216.913.713.31313.1
Public25.827.829.630.430.629.6

Strides Pharma Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day2.6 L5.01 L51.94%
Week1.94 L3.94 L49.21%
1 Month1.45 L2.99 L48.51%
6 Month1.64 L4.9 L33.39%

Strides Pharma SWOT Analysis

Strengths28
Weakness3
Opportunity4
Threats0

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Undervalued Growth Stocks

Strong Momentum: Price above short, medium and long term moving averages

Jim Slater's Zulu Principle (Discover Growth Stocks)

Relative Outperformance versus Industry over 1 Month

Relative Outperformance versus Industry over 1 Year

Companies with high TTM EPS Growth

Strong QoQ EPS Growth in recent results

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 3 quarters

Annual Net Profits improving for last 2 years

Companies with decreasing Promoter pledge

RSI indicating price strength

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Strides Pharma Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
22 Jul, 20254FINAL22 Jul, 2025Equity Share
09 Sep, 20242.5FINAL09 Sep, 2024Equity Share
04 Aug, 20231.5FINAL04 Aug, 2023Equity Share
05 Aug, 20212.5FINAL06 Aug, 2021Equity Share
24 Jul, 20202FINAL27 Jul, 2020Equity Share
22 Aug, 201912INTERIM23 Aug, 2019Equity Share
19 Jul, 20193FINALEquity Share
12 Sep, 20182FINALEquity Share
07 Sep, 20174.5FINALEquity Share
21 Jul, 20164FINALEquity Share

Strides Pharma Stock Comparison

Financials
Price (₹)₹1,546.20₹614.65₹783.65₹4,812.80₹589.70₹1,463.50
% Change-0.63%3.73%1.40%0.29%9.26%-0.67%
Revenue TTM (₹ Cr)--₹1,598.19₹1,348.51₹724.81₹1,419.33
Net Profit TTM (₹ Cr)--₹206.20₹293.49₹204.17₹20.10
PE TTM--61.7027.1032.90840.10
1 Year Return46.52-0.0859.34-6.7623.63-15.92
ROCE30.2434.7834.76-35.593.26

FAQ's on STAR

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy